Timwell Corporation

Timwell Corporation is a Hong Kong-based healthcare investment company primarily focused on the cardiovascular medical device sector. The company is best known for its strategic partnership with Medtronic, which was established to develop and commercialize transcatheter aortic valve replacement (TAVR) therapies in China. Through this joint venture, Timwell facilitates the localization of Medtronic's CoreValve technology to address the growing needs of Chinese patients with aortic stenosis. Additionally, Timwell holds a significant equity stake in Sino Medical Sciences Technology (Sinomed), a prominent developer of interventional cardiology products including drug-eluting stents. The corporation serves as a strategic bridge, combining international medical innovation with local market expertise and capital. Its activities are central to the expansion of advanced structural heart and coronary interventions in the Asia-Pacific region.